Parasitology Tests Market
Number of pages: 100 | Report Format: PDF | Published date: April 03, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 6.1 billion |
|
Revenue Forecast in 2031 |
US$ 9.23 billion |
|
CAGR |
5.3% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Techniques, Pathogen Type, Sample Type, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global parasitology tests market was valued at US$ 6.1 billion in 2022 and is expected to register a revenue CAGR of 5.3% to reach US$ 9.23 billion by 2031.
Parasitology Tests Market Fundamentals
Parasitology tests are medical laboratory tests that detect and identify parasites in a patient's body. Depending on the suspected parasite, these tests are conducted on bodily fluids such as blood, stool, urine, and other tissues. Parasites can cause various illnesses, from mild symptoms such as diarrhea and stomach cramps to severe diseases such as malaria and leishmaniasis. Identifying the type of parasite responsible for the infection is crucial for effectively treating and managing the disease. Some common parasitology tests include stool examination for intestinal parasites, blood smear for malaria parasites, serological tests for antibodies against specific parasites, and PCR (polymerase chain reaction) tests to detect parasite DNA in blood or tissue samples.
[686776]
Parasitology Tests Market Dynamics
The rising incidence of parasitic infections is attributed to globalization, travel, migration, and climate change, resulting in a surge in demand for parasitology tests. Early detection and efficient management of these infections have become crucial, driving the growth of parasitology test market revenue. According to the WHO, an estimated 1.5 billion people, or 24% of the world's population, have soil-transmitted helminth (STH) infections, making it one of the most prevalent infections globally. Developing advanced technologies and techniques for parasitology testing has led to more accurate and reliable results. Non-invasive testing methods such as serology, antigen detection, and molecular diagnostics are gaining popularity as they offer greater convenience, faster results, and reduced patient discomfort.
Moreover, the demand for POC testing is increasing, providing rapid and accurate results and allowing for early diagnosis and treatment. This is particularly significant in low-resource settings with limited access to laboratory facilities. There is a growing awareness among healthcare professionals and the general public about the importance of early diagnosis and treatment of parasitic infections. This is propelling the market revenue growth.
Governments and healthcare organizations are also promoting initiatives and programs to control and eliminate these infections, which is expected to boost the demand for parasitology tests. Pharmaceutical and biotechnology companies are investing heavily in the research and development of new parasitology tests, which is expected to drive innovation and further growth in the market. However, parasitology tests may be expensive, making them inaccessible for certain populations or healthcare systems with limited budgets, thus restricting market revenue growth. Additionally, the lack of awareness among the general public in some middle- and low-income countries about the importance of early diagnosis and treatment of parasitic infections is also hindering the market revenue growth.
The global parasitology tests market is expected to grow significantly during the forecast period due to the consistently growing incidence of parasitic infections and the increasing awareness about the importance of early detection and treatment. The market is rising due to significant technological advancements, such as the development of portable and point-of-care diagnostic devices. These devices offer rapid and accurate diagnosis of parasitic infections, particularly in remote and underdeveloped areas.
Based on region, North America and Europe currently dominate the parasitology tests market due to well-established healthcare infrastructure and high awareness levels among the population. However, Asia Pacific expects significant revenue growth in the coming years due to the high burden of parasitic infections in countries such as India and China.
The market is dominated by established players such as Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., and Becton, Dickinson & Company, offering a wide range of parasitology tests and equipment. However, many smaller players and startups are also entering the market, particularly in molecular diagnostics.
Parasitology Tests Market Ecosystem
The global parasitology tests market is analyzed from five perspectives: techniques, pathogen type, sample type, end-user, and region.
Parasitology Tests Market by Techniques
[965767]
Based on the techniques, the global parasitology tests market is segmented into microscopic identification, molecular techniques, immunological techniques, rapid diagnostic tests (RDTs), and others.
The microscopic identification segment dominated the parasitology tests market with the largest revenue share. Microscopic identification is a well-established and highly accurate method for identifying parasitic infections. Microscopic identification has been used for many years to diagnose parasitic infections. It is a well-established method that has a large customer base. Microscopic identification is a widely available method that can be performed in most clinical or laboratory settings, making it accessible to many patients. Unlike newer diagnostic technologies, microscopic identification is relatively low-cost, making it an affordable option for many healthcare systems. There are many parasitic infections, and microscopic identification can be used to diagnose a wide range of these infections. This means there is a large market for microscopic identification tests in the field of parasitology.
The molecular techniques segment is expected to register a lucrative revenue growth rate during the forecast period. The molecular techniques segment is further sub-segmented into ELISA, hemagglutination assay, and others. Molecular techniques offer higher sensitivity and specificity than traditional parasitology diagnostic methods, which leads to more accurate and reliable results. The development of molecular techniques has led to the creation of multiplex assays that can detect multiple parasites simultaneously, which is faster and more cost-effective than running individual tests for each parasite. The increasing prevalence of parasitic infections, particularly in developing countries, has created a need for more advanced and efficient diagnostic tools, driving demand for molecular techniques.
Parasitology Tests Market by Pathogen Type
Based on the pathogen type, the global parasitology tests market is segmented into protozoa, helminths, and arthropods.
The protozoa segment accounts for the highest revenue share of the parasitology tests market. The rising prevalence of protozoan parasites globally is increasing the demand for parasitology tests. The diverse range of infections caused by protozoan parasites, such as malaria, leishmaniasis, and trypanosomiasis, has created a substantial need for accurate diagnostic tests to identify these infections. According to the WHO, the estimated number of malaria cases globally was 247 million in 2021. Several well-established and highly accurate diagnostic methods exist for protozoan parasites, including microscopic identification, serology, and molecular tests. These methods have been used for many years and have a large customer base. There is ongoing research and development in the field of protozoan parasite diagnostics, leading to the development of new and innovative diagnostic technologies. Additionally, many governments and healthcare organizations are promoting initiatives and programs to control and eliminate protozoan parasite infections, which is expected to boost the demand for diagnostic tests in this segment and hence drive the segment's revenue share.
Parasitology Tests Market by Sample Type
Based on the sample type, the global parasitology tests market is segmented into blood, urine, feces, cerebrospinal fluid (CSF), and others.
The feces sample segment accounted for a significant revenue share of the parasitology tests market 2022. The high concentration of parasites in fecal samples makes them an effective diagnostic tool for many parasitic infections. This is because the parasites are more easily detected and identified, leading to accurate diagnoses. Furthermore, collecting a stool sample is a non-invasive and simple procedure appealing to healthcare providers and patients. Fecal samples can diagnose various parasitic infections, including intestinal parasites such as Giardia and Entamoeba histolytica. This results in a significant market revenue share in the global fecal-based diagnostic tests in the parasitology tests market. Additionally, well-established and reliable diagnostic methods for fecal-based parasitic infections, such as microscopy, antigen detection, and molecular tests, have been used for many years and have a large customer base.
Parasitology Tests Market by End User
Based on the end user, the global parasitology tests market is segmented into hospital laboratories, diagnostic centers, and others.
With the prominent revenue share, the hospital laboratories segment dominated the parasitology tests market. Hospital laboratories possess the necessary infrastructure and equipment, such as advanced microscopy, antigen detection, and molecular testing, which allows for a wide range of diagnostic tests to be performed on samples obtained from patients. Additionally, they have trained personnel, including medical technologists, microbiologists, and pathologists, with the expertise to perform parasitology tests accurately and efficiently, ensuring reliable and high-quality results. Furthermore, hospitals and laboratories cater to a broad customer base, including inpatients, outpatients, and referral cases, creating a great demand for parasitology tests. They also collaborate closely with healthcare providers to diagnose and treat patients with parasitic infections, ensuring accurate diagnoses, appropriate treatment, and optimizing patient outcomes. They have quality control measures to ensure the accuracy and reliability of parasitology test results, which is important for maintaining patient trust and confidence in the healthcare system.
Parasitology Tests Market by Region
Geographically, the global parasitology tests market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominates the parasitology tests market, with the largest revenue share in 2022. The rising prevalence of parasitic infections in the region increases the demand for parasitology tests. North America has some of the world's most advanced healthcare infrastructure and facilities. This has allowed for the rapid adoption of new and innovative parasitology tests, significantly driving revenue growth in the regional market. The regulatory framework for North America's medical devices and diagnostic tests is robust and well-established. This has created a favorable environment for companies to develop and commercialize parasitology tests. There has been a growing emphasis on preventive healthcare in North America. This has led to an increased demand for parasitology tests for early detection and prevention of parasitic infections. Moreover, major companies present in the region are also expected to boost regional revenue growth.
Asia Pacific is expected to experience a lucrative market revenue during the forecast period. The growing prevalence of parasitic infections such as dengue fever, malaria, and other neglected tropical diseases is increasing the demand for the parasitology tests market. Governments and healthcare organizations in the region increasingly recognize the importance of diagnostics in disease management, leading to greater investment in healthcare infrastructure and diagnostic tools. Recently, Asia Pacific's rapid economic growth has led to increased investment in healthcare infrastructure, including laboratories and diagnostic facilities. The Asia Pacific region houses several emerging economies, such as India and China, which are experiencing rapid revenue growth in healthcare and are becoming major markets for parasitology tests.
Competitive Landscape of Parasitology Tests Market
The prominent players operating in the global parasitology tests market are:
Strategic Developments in Parasitology Tests Market
The expected size of the global parasitology tests market in 2031 is valued to be US$ 9.23 billion.
Based on region, North America has the largest market share, and Asia Pacific is expected to be the fastest-growing region during the forecast period.
The prominent players operating in the global parasitology tests market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Abbott Laboratories, Inc., and bioMeriuex SA.
The protozoa segment dominates the global parasitology tests market.
Some market restraints include the high cost related to parasitology tests and the lack of awareness in developing countries.
*Insights on financial performance are subject to the availability of information in the public domain